Search Results

This kit is intended for the quantitation of kappa free light chains in serum and urine on the Roche Hitachi 911 and Hitachi 912. Measurement of the various amounts of the different types of light chains aids in the diagnosis and monitoring of multiple myelomas, lymphocytic neoplasms, Waldenstrom's macroglobulinemia and connective tissue diseases, such as systemic lupus erythematosus.

Not Found

The provided text is a 510(k) summary for the FREELITE Human Kappa Free Kit, an in vitro diagnostic device. This document does not describe a study that involves an AI algorithm, human readers, or image analysis. Therefore, I cannot extract the information required to answer your prompt, as the questions pertain to studies involving AI and human-in-the-loop performance, which are not relevant to this type of medical device submission.

Specifically, the document is a clearance letter from the FDA stating that the device is substantially equivalent to a legally marketed predicate device. It briefly mentions the intended use of the kit (quantitation of kappa free light chains in serum and urine) and its application in aiding the diagnosis and monitoring of certain conditions.

To reiterate, the questions you've asked are designed for studies evaluating AI systems, not for submissions related to traditional in vitro diagnostic kits like the one described.

Ask a specific question about this device